Type I collagen

Type I collagen is the most abundant structural protein in mammalian extracellular matrices, forming fibrils that provide tensile strength and integrity to connective tissues such as skin, bone, tendon, and cornea[1][3]. It is a heterotrimer composed of two α1 chains and one α2 chain forming a triple helix, which further assembles into higher-order fibrils and fibers through hierarchical self-organization[1][3]. In tissue engineering, type I collagen is processed into various scaffold forms (hydrogels, sponges, membranes) to serve as bioactive, biodegradable, and cell-adhesive matrices, mimicking the structure and function of native ECM to support cell growth and tissue regeneration[1][3]. However, "Type-I collagen matrix scaffolding" does not refer to a specific receptor, enzyme, or canonical drug target protein: it describes a biomaterial or scaffold, not a conventional molecular target[1][3]. Thus, while crucial in tissue engineering and certain pathological states (fibrosis, abnormal healing), it does not qualify as a druggable molecular target in the conventional sense.

Other names

Collagen type ICollagen IType-I collagen

null (as above, drugs indirectly reduce type I collagen synthesis or deposition by modulating gene expression or signaling pathways such as TGF-β; the polymerized matrix is not a receptor or catalytic site with conventional mechanisms).